Sayaka Nagami
2PUBLICATIONS
4CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (2)
Sort by Publication Date:
|Nov 25, 2020
Long-term safety and efficacy of emicizumab for up to 5.8 years and patients' perceptions of symptoms and daily life: A phase 1/2 study in patients with severe haemophilia A.Midori Shima, Azusa Nagao, Masashi Taki
|Sep 14, 2019
A multicentre, open-label study of emicizumab given every 2 or 4 weeks in children with severe haemophilia A without inhibitors.Midori Shima, Keiji Nogami, Sayaka Nagami
Pageof 1
